Neurochemical profiles of some novel psychoactive substances - Test2 - elhamkhani - TriplyDB

Neurochemical profiles of some novel psychoactive substances

Neurochemical profiles of some novel psychoactive substances

http://www.wikidata.org/entity/Q34319162

about

Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Legal highs: staying on top of the flood of novel psychoactive substances Substituted methcathinones differ in transporter and receptor interactions Novel molecular targets of dezocine and their clinical implications Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.Acute 5-(2-aminopropyl)benzofuran (5-APB) intoxication and fatality: a case report with postmortem concentrations.Risky Decisions in a Lottery Task Are Associated with an Increase of Cocaine Use.Synthetic cathinones and their rewarding and reinforcing effects in rodents.Characterization of the pyrolysis products of methiopropamine.Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs.Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.Pharmacological profile of novel psychoactive benzofurans.The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Novel psychoactive substances of interest for psychiatry.Effects of α-pyrrolidinopentiophenone and 4-methyl-N-ethylcathinone, two synthetic cathinones commonly found in second-generation "bath salts," on intracranial self-stimulation thresholds in rats.Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.Psychostimulant Abuse and HIV Infection: cocaine, methamphetamine, and "bath salts" cathinone analogues.The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis.Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride (NRG-1), 6-(2-aminopropyl) benzofuran (benzofury/ 6-APB) and NRG-2 with review of available evidence-based literature.Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions."Not for human consumption": a review of emerging designer drugs.Psychostimulant Effect of the Synthetic Cannabinoid JWH-018 and AKB48: Behavioral, Neurochemical, and Dopamine Transporter Scan Imaging Studies in Mice.4,4'-Dimethylaminorex ("4,4'-DMAR"; "Serotoni") misuse: A Web-based study.Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases.Reporting Two Fatalities Associated with the Use of 4-Methylethcathinone (4-MEC) and a Review of the Literature.Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the 'benzofuran' compounds. A report from the United Kingdom National Poisons Information Service.Staphylococcus aureus bacteraemia associated with injected new psychoactive substances.Methiopropamine in blood samples from drivers suspected of being under the influence of drugs.Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents Formation of odd-electron product ions in collision-induced fragmentation of electrospray-generated protonated cathinone derivatives: aryl α-primary amino ketones.Cytotoxic effects of psychotropic benzofuran derivatives, N-methyl-5-(2-aminopropyl)benzofuran and its N-demethylated derivative, on isolated rat hepatocytes.Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium.Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats.An Internet Study of User's Experiences of the Synthetic Cathinone 4-Methylethcathinone (4-MEC).Preventive effects of fructose and N-acetyl-L-cysteine against cytotoxicity induced by the psychoactive compounds N-methyl-5-(2-aminopropyl)benzofuran and 3,4-methylenedioxy-N-methamphetamine in isolated rat hepatocytes.Intended and unintended use of cathinone mixtures.

P2860

Q26752739-55429DE4-51F0-4235-8A03-0978BCC61985 Q26799231-B8C4746E-AAC9-4313-9253-3383E927BF48 Q28288908-4D19C99A-25A0-4E4C-8EAF-3D3346D1B9DC Q28658148-B9B88295-D303-41CA-8321-E2B968BC4F91 Q30251771-123FC06C-F6D2-4A88-B269-8F5738298168 Q30368986-3624AE7B-DA4F-46A8-BE34-F31E251426BC Q30382802-636F371E-2E45-416A-8209-C3AAA693FA4A Q34352354-2AEABD6B-83E3-4220-9680-1C8C44AAAFF5 Q34380721-87AA545A-03C6-4618-B446-B05698E86635 Q34419823-5FCE9151-ED57-4E2C-BA4C-EB75BCA17370 Q34451894-51923335-C65C-4716-847B-FDAF00672421 Q34466872-C995F215-A7B8-4878-BC00-95C486FA7240 Q34546304-A0F60485-8D33-4B2E-8010-6A180088AFDA Q34667835-363A169C-20BA-4F91-85B0-ADB2E3E8AFF9 Q35203582-BCD233DF-B39A-4541-83A6-CC3705470C48 Q35754464-5B4BB7FF-DEA2-4B2B-AA02-D48983E09D9E Q36091506-C7655AB0-ED80-48CC-9AB2-C0BAD7561D5F Q36200336-95929880-ABFA-4BF2-A480-5B7181388217 Q37158450-7E398CE4-DB10-4BDF-B053-D99811A6B6DC Q37165401-2AFDAA13-5444-4B7C-88BA-B3ADAA733981 Q38123777-0E00DDF7-21E1-421A-9C90-E5E10D23D884 Q38195230-98A1CCDC-DAE1-4D49-BCA3-38DE005FD895 Q38202898-29608DE7-590D-417E-A33C-113C4A12D84D Q38616780-6A74D8CF-44BE-4121-85EF-C7E471F12AF4 Q38705409-65F9321C-109E-4FD1-AF81-20A24AEF5A3D Q38850097-521593CC-7D45-4556-BAAA-7A1586DAB8EF Q38894030-E40975F8-E81F-48BE-AD44-CB57EE5352DD Q39026719-90C6B0D5-4CA4-457D-ACAF-B43ECA01D74D Q39703486-A90C1EC6-670E-41F5-80EC-40D3BE2A1B0B Q40185434-EA5C009C-4665-40E0-B8C2-C66C096A9607 Q40918288-3E1826E5-5B85-47D2-B76F-361992A83C99 Q41072507-EC48A022-568B-42A7-8FD5-EC702CC46E6F Q42395888-47DCB69B-A050-43AF-B1A3-9076C0898EA7 Q46475968-C3638D4A-BFCC-4E9F-8ECF-C78795FCAED5 Q46533859-D334B2DD-49F8-4E7E-88E2-B0D80E9DA8B7 Q47342074-3D7F86E3-D52A-4B66-BEA2-D949B53B9FAE Q47551303-4213637A-A28C-4BD7-8C8F-C8724FA6A32C Q47585671-B1A49077-9EBD-4675-A629-93A4F6342929 Q48053078-F47B76F9-9289-4D4D-A6AD-9F33CA7B036A Q48211628-9ADC1B2F-39B3-4965-8912-123FE3D3FCBD

P2860

Neurochemical profiles of some novel psychoactive substances

http://www.wikidata.org/entity/Q34319162

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Neurochemical profiles of some novel psychoactive substances

@ast

Neurochemical profiles of some novel psychoactive substances

@en

Neurochemical profiles of some novel psychoactive substances

@nl

type

label

Neurochemical profiles of some novel psychoactive substances

@ast

Neurochemical profiles of some novel psychoactive substances

@en

Neurochemical profiles of some novel psychoactive substances

@nl

prefLabel

Neurochemical profiles of some novel psychoactive substances

@ast

Neurochemical profiles of some novel psychoactive substances

@en

Neurochemical profiles of some novel psychoactive substances

@nl

P1433

Q34319162-CCD54439-7E41-4947-B86E-0FA16F472422

P1476

Q34319162-A5944968-5492-428A-910A-5DFCB331D825

P2093

Q34319162-1E086885-D3FC-43D8-9DBC-E2C959A5020F

Q34319162-A079E1F1-8FD3-43DE-8AB5-1E1F0AC3FF39

Q34319162-D3F09529-62BF-43D0-A2B0-F5D2319CD7A3

Q34319162-D53DA410-0345-4E73-9A28-6B1FE4842AFE

Q34319162-DB61601E-A404-4E89-B39E-FA1040E68E96

P2860

Q34319162-01E8A8F2-49A4-49D2-9B0F-68210E550081

Q34319162-03475E9E-F063-425C-8316-5C0647A44064

Q34319162-042F9430-7F15-4D60-A47E-1CDB9BDEAE85

Q34319162-089964A5-0E8F-4816-BFDD-89029457FDBF

Q34319162-17495B53-2352-4EEC-875B-D21E4552C8C3

Q34319162-230EFD9B-DF00-4EA0-86D0-B1144E6C487D

Q34319162-38AD540F-9D25-4D7E-9A63-2418BC131D74

Q34319162-4CABDAE5-5AF8-44C3-B3D9-8308C32FCCFA

Q34319162-4DF40A26-1723-43F7-8509-445A6F1A6179

Q34319162-4F6CBF25-C51D-441A-ACB8-7D3877CF2D3E

P304

Q34319162-719ACB24-8A29-4EC5-B035-C96C682F8310

P31

Q34319162-28026BF3-8B4A-4417-9B00-AEC1297FC84E

P356

Q34319162-D95335E7-F45B-4820-8F82-B78F13D08E7B

P407

Q34319162-91B04F05-0C57-4212-ACD7-42C751B0C9F6

P433

Q34319162-16D9EC04-380D-4451-98FE-ACCDD163EF2F

P478

Q34319162-D20041BF-EC79-4DD0-85BA-039E3DAE716C

P50

Q34319162-32C3A236-E190-4677-A53C-62DD77CC230D

P577

Q34319162-038E5D01-56FF-4E0A-8A00-7F9A29109E55

P698

Q34319162-E35CD88A-DA9E-4CDD-89E4-D6987FC217F7

P921

Q34319162-D3DC4EF8-8DC3-4AD8-88E2-8E86EA6BCB45

P932

Q34319162-99442BFD-84D5-42DC-9A8A-BC88601139E5

P356

J.EJPHAR.2012.12.006

P1433

European Journal of Pharmacology

P1476

Neurochemical profiles of some novel psychoactive substances

@en

P2093

Bryan L Roth

http://www.w3.org/2001/XMLSchema#string

Les Iversen

http://www.w3.org/2001/XMLSchema#string

Ric Treble

http://www.w3.org/2001/XMLSchema#string

Simon Gibbons

http://www.w3.org/2001/XMLSchema#string

Vincent Setola

http://www.w3.org/2001/XMLSchema#string

P2860

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue

Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats

Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans

Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment

Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease

P304

147-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJPHAR.2012.12.006

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

700

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23261499

http://www.w3.org/2001/XMLSchema#string

P921

P932

3582025

http://www.w3.org/2001/XMLSchema#string